Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Women with BRCA1 or BRCA2 mutations renegotiating a post-prophylactic mastectomy identity: self-image and self-disclosure.

Kenen RH, Shapiro PJ, Hantsoo L, Friedman S, Coyne JC.

J Genet Couns. 2007 Dec;16(6):789-98. Epub 2007 Oct 5.

PMID:
17917796
2.

Breast cancer and ovarian cancer genetics.

Edlich RF, Winters KL, Lin KY.

J Long Term Eff Med Implants. 2005;15(5):533-45. Review.

PMID:
16218901
3.

Prophylactic mastectomy and genetic testing: an update.

Houshmand SL, Campbell CT, Briggs SE, McFadden AW, Al-Tweigeri T.

Oncol Nurs Forum. 2000 Nov-Dec;27(10):1537-47; quiz 1548-9. Review.

PMID:
11103373
4.

Prophylactic surgery for women at high risk for breast cancer.

Blanchard DK, Hartmann LC.

Clin Breast Cancer. 2000 Jul;1(2):127-34; discussion 135. Review.

PMID:
11899651
5.

Clinical management of women with genomic BRCA1 and BRCA2 mutations.

Chang J, Elledge RM.

Breast Cancer Res Treat. 2001 Sep;69(2):101-13. Review.

PMID:
11759816
6.

Prophylactic bilateral mastectomy for breast cancer prevention.

Metcalfe KA.

J Womens Health (Larchmt). 2004 Sep;13(7):822-9. Review.

PMID:
15385076
7.

Familial breast and ovarian cancers.

Arai M, Utsunomiya J, Miki Y.

Int J Clin Oncol. 2004 Aug;9(4):270-82. Review.

PMID:
15375703
8.

Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation.

Metcalfe KA, Foulkes WD, Kim-Sing C, Ainsworth P, Rosen B, Armel S, Poll A, Eisen A, Gilchrist D, Chudley A, Ghadirian P, Maugard C, Lemire EG, Sun P, Narod SA.

Clin Genet. 2008 May;73(5):474-9. doi: 10.1111/j.1399-0004.2008.00988.x. Epub 2008 Mar 12. Review.

PMID:
18341607
9.

Breast cancer in women at high risk: the role of rapid genetic testing for BRCA1 and -2 mutations and the consequences for treatment strategies.

Francken AB, Schouten PC, Bleiker EM, Linn SC, Rutgers EJ.

Breast. 2013 Oct;22(5):561-8. doi: 10.1016/j.breast.2013.07.045. Epub 2013 Aug 21. Review.

PMID:
23972475
10.

Counseling the at risk patient in the BRCA1 and BRCA2 Era.

Barnes-Kedar IM, Plon SE.

Obstet Gynecol Clin North Am. 2002 Jun;29(2):341-66, vii. Review.

PMID:
12108833
11.

Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery.

Salhab M, Bismohun S, Mokbel K.

BMC Womens Health. 2010 Oct 20;10:28. doi: 10.1186/1472-6874-10-28. Review.

12.

Prophylactic mastectomy for the prevention of breast cancer.

Lostumbo L, Carbine N, Wallace J, Ezzo J.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD002748. Review. Update in: Cochrane Database Syst Rev. 2010;(11):CD002748.

PMID:
15495033
13.

Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.

Roukos DH, Briasoulis E.

Nat Clin Pract Oncol. 2007 Oct;4(10):578-90. Review.

PMID:
17898808
14.

Clinical management of BRCA1- and BRCA2-associated breast cancer.

Karp SE.

Semin Surg Oncol. 2000 Jun;18(4):296-304. Review.

PMID:
10805951
15.

Management updates for women with a BRCA1 or BRCA2 mutation.

Nusbaum R, Isaacs C.

Mol Diagn Ther. 2007;11(3):133-44. Review.

PMID:
17570734
Items per page

Supplemental Content

Write to the Help Desk